Close

Articles Posted in ranitidine

Updated:

More than 70,000 Zantac Lawsuits to Move Forward in Delaware State Court

A Delaware Superior Court Judge has allowed roughly 75,000 plaintiffs to be heard in Delaware courts regarding whether the drug Zantac caused cancer. This is a massive turn of events, as nearly 50,000 similar lawsuits were dismissed in federal courts just two years ago. In 2022, the federal judge in…

Updated:

Zantac Litigation Focused on Bladder, Liver, Esophageal, Gastric, and Pancreatic Cancers

In any product liability litigation, the injured person must ultimately prove that the injury was caused by the defective product (legal causation). A relatively easy example is when a lamp explodes and burns an individual, and in the post-explosion investigation the plaintiff discovers the lamp’s wiring was faulty and unreasonably…

Updated:

Court Rulings in Zantac Litigation Could Toss Many Cases: What This Means for You

After news broke that Zantac (the brand name for ranitidine) was linked to cancer, a large wave of lawsuits started making their way into state and federal courts. Many of these cases have been consolidated into the Zantac multi-district litigation, or MDL 2924. The Zantac MDL is still in the…

Updated:

Zantac Litigation: What If You Only Took the Generic Ranitidine?

Generic drugs are a big deal in the United States. According to the U.S. Food and Drug Administration (FDA), 90% of prescription medications are filled with a generic drug. One of the reasons so many people take generic medications is the cost savings. From 2007 to 2016, generic medications saved…

Updated:

Zantac Complaint, Part 3: Four Ways Ranitidine Tranforms into NDMA

In Part 2 of this series we looked at the development of ranitidine (brand name Zantac), its rise as a hugely profitable heartburn drug, and the discovery that the carcinogen NDMA was found in rantidine, eventually leading to its recall and removal from the market. In this Part 3 I…

Updated:

Zantac Master Complaint, Part 2: Invention of Ranitidine, Discovery of NDMA

In Part 1 I discussed the concept of the Master Complaint in product liability multi-district litigation, and we also set the table with the plaintiffs and the many defendant-companies involved in the Zantac litigation. Now let’s keep grinding through the Zantac Master Complaint. The story of Zantac, the presence of…

Updated:

Zantac Litigation Master Complaint Key Points, Part 1: The Parties Involved

If you truly want to learn about a particular litigation involving a defective product (such as Zantac), the best place to start is the Master Complaint. This is the lengthy comprehensive document filed by the plaintiffs in a multi-district litigation involving a defective product. This does not mean the case…

Updated:

Zantac: An Update and an Overview of Its Link to Cancer

Earlier this year I wrote a blog post that discussed the recent revelation that Zantac might cause cancer. Scientists found a link between N-Nitrosodimethylamine (NDMA), a likely cancer-causing substance, and ranitidine, the key ingredient in Zantac. A few things have changed since that blog post, such as the U.S. Food…

Updated:

Zantac: Overview of Recall and Lawsuits Due to Cancer-Causing NDMA

Many of us suffer from heartburn, and one of the most popular ways to treat it is by taking Zantac. Until recently, Zantac was considered a very safe medication and was available without a prescription. Given how well it worked, along with its affordable price and the perception of safety,…

Contact Us